Dead biotech shell companies Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
18:52
Jul 14
Jul 14
Dead biotech shells become crypto vehicles
Many crypto treasury vehicles are coming out of dead biotech shell companies. Failed single-drug biotechs often dissolve into shells with value, and their best exit may now be selling to crypto treasury promoters. Sonnet BioTherapeutics tripled after announcing a merger to buy Hyperliquid. He is looking to bet that these dead biotech shells sell out one by one.
MED
About Dead biotech shell companies Investor Commentary
Across the available history and selected sources, Buzzberg tracks Dead biotech shell companies across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Jonah Van Bourg.